Literature DB >> 9011689

Proliferation of smooth muscle cells in acute allograft vascular rejection.

J Amano1, S Ishiyama, T Nishikawa, H Tanaka, R Nagai, F Marumo, M Hiroe.   

Abstract

OBJECTIVES: To determine whether immune injury during acute cardiac rejection induces phenotypic modulation of arterial smooth muscle cells and lesion formation, we studied the expression of embryonic myosin heavy-chain isoform and degrees of intimal proliferation in aortas and coronary arteries of allografted rabbit hearts. Modulation of phenotype in arterial smooth muscle cells during acute vascular injury is a widely reported phenomenon, and proliferation and migration of medial smooth muscle cells contribute to development of intimal hyperplasia of arteries in response to immune injury.
METHODS: Rabbit hearts were heterotopically transplanted to the neck without immunosuppression. Hearts were harvested at 2, 5, 7, and 10 days after transplantation. Proliferation of smooth muscle cells was assessed by bromodeoxyuridine labeling. Staining for immunohistochemical indicators was done with use of monoclonal antibodies that recognize T lymphocytes and all types of smooth muscle cells (SM1), adult type of smooth muscle cells (SM2), and embryonic myosin heavy-chain isoform. Intimal thickening and luminal narrowing were assessed with a computer-assisted video image analysis system.
RESULTS: Intimal thickening and luminal narrowing in aortas and coronary arteries gradually increased in a time-dependent manner. The neointima thus formed consisted of proliferating smooth muscle cells positive for both SM1 and embryonic myosin heavy-chain isoform and massive T lymphocyte accumulation. Intimal proliferation was more prominent in aortas and large epicardial coronary arteries than in the intramyocardial small coronary arteries.
CONCLUSIONS: These findings suggest that allogeneic immune injury facilitates phenotypic modulation of smooth muscle cells, which may contribute to subsequent transplantation-associated atherosclerosis.

Entities:  

Mesh:

Year:  1997        PMID: 9011689     DOI: 10.1016/S0022-5223(97)70395-7

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  3 in total

1.  Granulation encapsulated stent: a new therapeutic approach for vascular implantation.

Authors:  Lilong Tang; Xiaochao Chen; Shuangbo Tang; Thomas LaLonde; Julius M Gardin
Journal:  Heart       Date:  2006-08-16       Impact factor: 5.994

2.  Characteristics of cardiac allograft vasculopathy induced by immunomodulation in the miniature Swine.

Authors:  Jun Amano; Tomohiro Akashima; Takamitsu Terasaki; Yuko Wada; Midori Ito-Amano; Jun-Ichi Suzuki; Mitsuaki Isobe
Journal:  Ann Thorac Cardiovasc Surg       Date:  2014-04-18       Impact factor: 1.520

3.  Genetic or pharmaceutical blockade of phosphoinositide 3-kinase p110δ prevents chronic rejection of heart allografts.

Authors:  Huijun Ying; Hongmei Fu; Marlene L Rose; Ann M McCormack; Padmini Sarathchandra; Klaus Okkenhaug; Federica M Marelli-Berg
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.